Home
About
Overview
Sharing Data
ORCID
Help
History (2)
A phase I study of selinexor combined with weekly carfilzomib and dexamethasone in relapsed/refractory multiple myeloma.
Targeting deubiquitinase activity with a novel small-molecule inhibitor as therapy for B-cell malignancies.
See All 2 Pages
Find People
Find Everything
Edit My Profile
My Person List (
0
)
Return to Top
Login
Username
Password